Fibroblasts facilitate chemotherapeutic drug-resistance development through the secretion of IL-11, and this latter via its receptor IL-11R activates the gp130/ JAK/STAT3 pathway, which is an anti-apoptosis signaling pathway in GC cells. This evidence concerns the gene STAT3 and gastric cancer.